EHA 2015: Defining therapeutic strategies in elderly acute myeloid leukemia

VJHemOnc has 1608 videos Subscribe Here

Description: The prognosis of elderly patients with acute myeloid leukemia (AML) remains poor despite recent therapeutic advances. At the 20th Congress of the European Hematology Association (EHA), Charles Craddock, FRCPath, FRCP, DPhil, BMBCh, of the University of Birmingham, Birmingham, UK, evaluates the current management options available for this patient population. Increasingly, biological age, rather than chronological age, is being used to help define appropriate treatment options for a patient, which can include allogeneic stem-cell transplantation, hypomethylating agents and investigational drugs.


The Video Journal of Hematological Oncology (VJHemOnc) is an independent, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve understanding and awareness of hematological malignancies.

Shared By : VJHemOnc
Posted on : 07/15/15
Added : 4 years ago